bayer public limited company Company Information
Company Number
00935048
Website
www.bayer.comRegistered Address
400 south oak way, reading, berkshire, RG2 6AD
Industry
Wholesale of pharmaceutical goods
Telephone
01182063000
Next Accounts Due
June 2024
Group Structure
View All
Shareholders
bayer global investments 100%
bayer public limited company Estimated Valuation
Pomanda estimates the enterprise value of BAYER PUBLIC LIMITED COMPANY at £921.1m based on a Turnover of £699.7m and 1.32x industry multiple (adjusted for size and gross margin).
bayer public limited company Estimated Valuation
Pomanda estimates the enterprise value of BAYER PUBLIC LIMITED COMPANY at £339.1m based on an EBITDA of £32.2m and a 10.53x industry multiple (adjusted for size and gross margin).
bayer public limited company Estimated Valuation
Pomanda estimates the enterprise value of BAYER PUBLIC LIMITED COMPANY at £396.1m based on Net Assets of £185.7m and 2.13x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Bayer Public Limited Company AI Business Plan
In just minutes, we combine Pomanda’s company and industry data with cutting edge Artificial Intelligence to build a comprehensive 27 section business plan. You then have 60 days to tailor the information, decide which sections to include or exclude, and add your own branding logos, images and color scheme to create your perfect plan.
Bayer Public Limited Company Overview
Bayer Public Limited Company is a live company located in berkshire, RG2 6AD with a Companies House number of 00935048. It operates in the wholesale of pharmaceutical goods sector, SIC Code 46460. Founded in July 1968, it's largest shareholder is bayer global investments with a 100% stake. Bayer Public Limited Company is a mature, mega sized company, Pomanda has estimated its turnover at £699.7m with declining growth in recent years.
Upgrade for unlimited company reports & a free credit check
Bayer Public Limited Company Health Check
Pomanda's financial health check has awarded Bayer Public Limited Company a 4 rating. We use a traffic light system to show it exceeds the industry average on 4 measures and has 4 areas for improvement. Company Health Check FAQs
4 Strong
4 Regular
4 Weak
Size
annual sales of £699.7m, make it larger than the average company (£26m)
£699.7m - Bayer Public Limited Company
£26m - Industry AVG
Growth
3 year (CAGR) sales growth of -1%, show it is growing at a slower rate (4.6%)
-1% - Bayer Public Limited Company
4.6% - Industry AVG
Production
with a gross margin of 23.5%, this company has a comparable cost of product (26.3%)
23.5% - Bayer Public Limited Company
26.3% - Industry AVG
Profitability
an operating margin of 4.1% make it as profitable than the average company (4%)
4.1% - Bayer Public Limited Company
4% - Industry AVG
Employees
with 698 employees, this is above the industry average (38)
698 - Bayer Public Limited Company
38 - Industry AVG
Pay Structure
on an average salary of £127.6k, the company has a higher pay structure (£72.3k)
£127.6k - Bayer Public Limited Company
£72.3k - Industry AVG
Efficiency
resulting in sales per employee of £1m, this is more efficient (£607k)
£1m - Bayer Public Limited Company
£607k - Industry AVG
Debtor Days
it gets paid by customers after 42 days, this is earlier than average (59 days)
42 days - Bayer Public Limited Company
59 days - Industry AVG
Creditor Days
its suppliers are paid after 17 days, this is quicker than average (28 days)
17 days - Bayer Public Limited Company
28 days - Industry AVG
Stock Days
it holds stock equivalent to 79 days, this is in line with average (66 days)
79 days - Bayer Public Limited Company
66 days - Industry AVG
Cash Balance
has cash to cover current liabilities for 0 weeks, this is less cash available to meet short term requirements (12 weeks)
0 weeks - Bayer Public Limited Company
12 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 59.3%, this is a similar level of debt than the average (56.5%)
59.3% - Bayer Public Limited Company
56.5% - Industry AVG
bayer public limited company Credit Report and Business Information
Bayer Public Limited Company Competitor Analysis
Perform a competitor analysis for bayer public limited company by selecting its closest rivals and benchmarking them against 12 key performance metrics.
bayer public limited company Ownership
BAYER PUBLIC LIMITED COMPANY group structure
Bayer Public Limited Company has 6 subsidiary companies.
Ultimate parent company
BAYER AG
#0000526
BAYER GLOBAL INVESTMENTS BV
#0054086
2 parents
BAYER PUBLIC LIMITED COMPANY
00935048
6 subsidiaries
bayer public limited company directors
Bayer Public Limited Company currently has 3 directors. The longest serving directors include Mr Thorsten Gerdau (Sep 2019) and Mr Vinit Jindal (Aug 2021).
officer | country | age | start | end | role |
---|---|---|---|---|---|
Mr Thorsten Gerdau | England | 57 years | Sep 2019 | - | Director |
Mr Vinit Jindal | England | 50 years | Aug 2021 | - | Director |
Dr Ramon Payano Baez | England | 52 years | Sep 2021 | - | Director |
BAYER PUBLIC LIMITED COMPANY financials
Bayer Public Limited Company's latest turnover from December 2022 is £699.7 million and the company has net assets of £185.7 million. According to their latest financial statements, Bayer Public Limited Company has 698 employees and maintains cash reserves of £1 million as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Turnover | 699,731,000 | 750,622,000 | 688,967,000 | 710,711,000 | 721,798,000 | 720,354,000 | 583,992,000 | 443,547,000 | 447,308,000 | 410,044,000 | 410,971,000 | 384,526,000 | 374,567,000 | 371,589,000 |
Other Income Or Grants | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Cost Of Sales | 534,933,000 | 582,506,000 | 529,103,000 | 530,456,000 | 531,671,000 | 529,415,000 | 421,164,000 | 294,267,000 | 298,652,000 | 279,311,000 | 271,440,000 | 255,317,000 | 235,741,000 | |
Gross Profit | 164,798,000 | 168,116,000 | 159,864,000 | 180,255,000 | 190,127,000 | 190,939,000 | 162,828,000 | 149,280,000 | 148,656,000 | 130,733,000 | 139,531,000 | 129,209,000 | 138,826,000 | |
Admin Expenses | 136,265,000 | 135,795,000 | 127,609,000 | 142,174,000 | 158,936,000 | 148,152,000 | 136,608,000 | 129,676,000 | 130,142,000 | 107,866,000 | 111,065,000 | 86,530,000 | 100,458,000 | |
Operating Profit | 28,533,000 | 32,321,000 | 32,255,000 | 38,081,000 | 31,191,000 | 42,787,000 | 26,220,000 | 19,604,000 | 18,514,000 | 22,867,000 | 28,466,000 | 42,679,000 | 38,368,000 | 30,007,000 |
Interest Payable | 7,863,000 | 3,615,000 | 4,596,000 | 4,731,000 | 5,518,000 | 4,601,000 | 2,589,000 | 2,341,000 | 583,000 | 1,760,000 | 1,356,000 | 22,672,000 | 43,960,000 | 19,993,000 |
Interest Receivable | 2,965,000 | 0 | 167,000 | 0 | 1,527,000 | 853,000 | 257,000 | 35,000 | 31,000 | 802,000 | 993,000 | 25,638,000 | 23,936,000 | 20,739,000 |
Pre-Tax Profit | 43,606,000 | 42,015,000 | 25,240,000 | 64,535,000 | 47,770,000 | 86,676,000 | -49,309,000 | 17,365,000 | 22,667,000 | 22,449,000 | 28,710,000 | 45,645,000 | 39,311,000 | 31,621,000 |
Tax | -3,587,000 | -5,482,000 | -5,472,000 | -6,642,000 | -5,110,000 | -6,907,000 | -4,578,000 | -3,222,000 | -3,552,000 | -5,820,000 | -6,934,000 | -11,699,000 | -10,947,000 | -9,446,000 |
Profit After Tax | 40,019,000 | 36,533,000 | 19,768,000 | 57,893,000 | 42,660,000 | 79,769,000 | -53,887,000 | 14,143,000 | 19,115,000 | 16,629,000 | 21,776,000 | 33,946,000 | 28,364,000 | 22,175,000 |
Dividends Paid | 20,000,000 | 20,000,000 | 30,000,000 | 50,000,000 | 0 | 0 | 0 | 15,000,000 | 75,000,000 | 0 | 50,000,000 | 20,000,000 | 50,000,000 | 40,000,000 |
Retained Profit | 20,019,000 | 16,533,000 | -25,919,000 | 10,282,000 | 42,660,000 | 79,769,000 | -53,887,000 | -857,000 | -55,885,000 | 16,629,000 | -28,224,000 | 13,946,000 | -21,636,000 | -17,825,000 |
Employee Costs | 89,031,000 | 82,263,000 | 79,257,000 | 81,799,000 | 80,881,000 | 73,574,000 | 70,379,000 | 67,348,000 | 61,366,000 | 55,979,000 | 54,470,000 | 51,302,000 | 48,840,000 | 52,529,000 |
Number Of Employees | 698 | 658 | 714 | 748 | 770 | 739 | 720 | 732 | 718 | 691 | 712 | 673 | 668 | 701 |
EBITDA* | 32,203,000 | 35,999,000 | 35,896,000 | 42,377,000 | 35,549,000 | 46,106,000 | 31,726,000 | 22,572,000 | 23,093,000 | 26,731,000 | 32,400,000 | 46,643,000 | 42,305,000 | 35,339,000 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Tangible Assets | 19,439,000 | 404,764,000 | 140,466,000 | 154,075,000 | 162,552,000 | 124,077,000 | 8,882,000 | 2,760,000 | 3,331,000 | 2,803,000 | 2,892,000 | 3,320,000 | 3,677,000 | 4,020,000 |
Intangible Assets | 1,257,000 | 748,000 | 563,000 | 376,000 | 0 | 2,775,000 | 4,955,000 | 7,876,000 | 9,956,000 | 3,747,000 | 6,526,000 | 9,795,000 | 13,063,000 | 16,334,000 |
Investments & Other | 189,880,000 | 121,423,000 | 109,234,000 | 125,820,000 | 125,820,000 | 105,250,000 | 57,613,000 | 136,010,000 | 154,996,000 | 137,814,000 | 0 | 661,000 | 0 | 0 |
Debtors (Due After 1 year) | 0 | 131,194,000 | 3,925,000 | 2,327,000 | 7,496,000 | 8,624,000 | 15,211,000 | 3,462,000 | 4,952,000 | 0 | 0 | 0 | 0 | 0 |
Total Fixed Assets | 210,576,000 | 274,318,000 | 137,104,000 | 154,451,000 | 142,659,000 | 126,852,000 | 86,661,000 | 150,108,000 | 173,235,000 | 144,364,000 | 9,418,000 | 13,776,000 | 16,740,000 | 20,354,000 |
Stock & work in progress | 117,192,000 | 144,108,000 | 168,440,000 | 149,966,000 | 109,067,000 | 103,835,000 | 70,052,000 | 27,099,000 | 18,818,000 | 15,772,000 | 18,222,000 | 11,389,000 | 12,122,000 | 11,108,000 |
Trade Debtors | 81,486,000 | 104,326,000 | 110,355,000 | 136,215,000 | 118,151,000 | 101,673,000 | 90,554,000 | 67,279,000 | 62,468,000 | 58,671,000 | 52,687,000 | 48,535,000 | 49,760,000 | 49,046,000 |
Group Debtors | 41,140,000 | 34,827,000 | 6,694,000 | 7,753,000 | 33,186,000 | 15,870,000 | 12,526,000 | 35,903,000 | 5,323,000 | 6,030,000 | 190,288,000 | 239,262,000 | 233,319,000 | 206,442,000 |
Misc Debtors | 4,376,000 | 2,604,000 | 17,247,000 | 1,913,000 | 3,076,000 | 2,331,000 | 4,421,000 | 3,316,000 | 2,592,000 | 2,473,000 | 2,871,000 | 2,970,000 | 3,700,000 | 3,044,000 |
Cash | 1,010,000 | 342,000 | 168,000 | 197,000 | 162,000 | 392,000 | 118,000 | 8,584,000 | 99,000 | 469,000 | 172,000 | 457,000 | 2,033,000 | 1,940,000 |
misc current assets | 0 | 0 | 0 | 10,826,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
total current assets | 245,204,000 | 288,149,000 | 303,523,000 | 306,870,000 | 263,642,000 | 224,101,000 | 177,671,000 | 142,181,000 | 89,300,000 | 83,415,000 | 264,240,000 | 302,613,000 | 300,934,000 | 271,580,000 |
total assets | 455,780,000 | 562,467,000 | 440,627,000 | 461,321,000 | 406,301,000 | 350,953,000 | 264,332,000 | 292,289,000 | 262,535,000 | 227,779,000 | 273,658,000 | 316,389,000 | 317,674,000 | 291,934,000 |
Bank overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Trade Creditors | 25,439,000 | 28,930,000 | 22,300,000 | 18,248,000 | 11,692,000 | 11,441,000 | 13,966,000 | 10,957,000 | 11,118,000 | 16,667,000 | 18,003,000 | 15,767,000 | 16,364,000 | 19,503,000 |
Group/Directors Accounts | 120,245,000 | 0 | 0 | 0 | 0 | 0 | 130,230,000 | 135,814,000 | 124,169,000 | 37,410,000 | 99,720,000 | 107,785,000 | 96,788,000 | 41,145,000 |
other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
hp & lease commitments | 3,086,000 | 2,853,000 | 2,752,000 | 2,387,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other current liabilities | 41,266,000 | 237,971,000 | 245,774,000 | 244,832,000 | 251,001,000 | 231,083,000 | 79,135,000 | 64,718,000 | 42,256,000 | 36,989,000 | 33,852,000 | 35,701,000 | 35,603,000 | 31,047,000 |
total current liabilities | 190,036,000 | 269,754,000 | 270,826,000 | 265,467,000 | 238,532,000 | 242,524,000 | 223,331,000 | 211,489,000 | 177,543,000 | 91,066,000 | 151,575,000 | 159,253,000 | 148,755,000 | 91,695,000 |
loans | 0 | 35,278,000 | 37,966,000 | 41,808,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
hp & lease commitments | 16,026,000 | 17,639,000 | 18,983,000 | 20,904,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
provisions | 64,033,000 | 119,974,000 | 81,088,000 | 98,570,000 | 68,426,000 | 102,330,000 | 88,839,000 | 19,030,000 | 27,380,000 | 5,916,000 | 4,801,000 | 4,991,000 | 7,677,000 | 10,101,000 |
total long term liabilities | 80,059,000 | 77,626,000 | 59,527,000 | 70,189,000 | 34,213,000 | 51,165,000 | 88,839,000 | 19,030,000 | 27,380,000 | 16,279,000 | 25,375,000 | 4,991,000 | 15,728,000 | 28,108,000 |
total liabilities | 270,095,000 | 347,380,000 | 330,353,000 | 335,656,000 | 272,745,000 | 293,689,000 | 312,170,000 | 230,519,000 | 204,923,000 | 107,345,000 | 176,950,000 | 164,244,000 | 164,483,000 | 119,803,000 |
net assets | 185,685,000 | 215,087,000 | 110,274,000 | 125,665,000 | 133,556,000 | 57,264,000 | -47,838,000 | 61,770,000 | 57,612,000 | 120,434,000 | 96,708,000 | 152,145,000 | 153,191,000 | 172,131,000 |
total shareholders funds | 185,685,000 | 215,087,000 | 110,274,000 | 125,665,000 | 106,640,000 | 57,264,000 | -47,838,000 | 61,770,000 | 57,612,000 | 120,434,000 | 96,708,000 | 152,145,000 | 153,191,000 | 172,131,000 |
Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Activities | ||||||||||||||
Operating Profit | 28,533,000 | 32,321,000 | 32,255,000 | 38,081,000 | 31,191,000 | 42,787,000 | 26,220,000 | 19,604,000 | 18,514,000 | 22,867,000 | 28,466,000 | 42,679,000 | 38,368,000 | 30,007,000 |
Depreciation | 3,435,000 | 3,536,000 | 3,566,000 | 4,296,000 | 2,400,000 | 1,024,000 | 2,577,000 | 837,000 | 660,000 | 593,000 | 665,000 | 696,000 | 666,000 | 739,000 |
Amortisation | 235,000 | 142,000 | 75,000 | 0 | 1,958,000 | 2,295,000 | 2,929,000 | 2,131,000 | 3,919,000 | 3,271,000 | 3,269,000 | 3,268,000 | 3,271,000 | 4,593,000 |
Tax | -3,587,000 | -5,482,000 | -5,472,000 | -6,642,000 | -5,110,000 | -6,907,000 | -4,578,000 | -3,222,000 | -3,552,000 | -5,820,000 | -6,934,000 | -11,699,000 | -10,947,000 | -9,446,000 |
Stock | -26,916,000 | -24,332,000 | 18,474,000 | 40,899,000 | 5,232,000 | 33,783,000 | 42,953,000 | 8,281,000 | 3,046,000 | -2,450,000 | 6,833,000 | -733,000 | 1,014,000 | 11,108,000 |
Debtors | -145,949,000 | 134,730,000 | -9,987,000 | -13,701,000 | 33,411,000 | 5,786,000 | 12,752,000 | 34,625,000 | 8,161,000 | -178,672,000 | -44,921,000 | 3,988,000 | 28,247,000 | 258,532,000 |
Creditors | -3,491,000 | 6,630,000 | 4,052,000 | 6,556,000 | 251,000 | -2,525,000 | 3,009,000 | -161,000 | -5,549,000 | -1,336,000 | 2,236,000 | -597,000 | -3,139,000 | 19,503,000 |
Accruals and Deferred Income | -196,705,000 | -7,803,000 | 942,000 | -6,169,000 | 19,918,000 | 151,948,000 | 14,417,000 | 22,462,000 | 5,267,000 | 3,137,000 | -1,849,000 | 98,000 | 4,556,000 | 31,047,000 |
Deferred Taxes & Provisions | -55,941,000 | 38,886,000 | -17,482,000 | 30,144,000 | -33,904,000 | 13,491,000 | 69,809,000 | -8,350,000 | 21,464,000 | 1,115,000 | -190,000 | -2,686,000 | -2,424,000 | 10,101,000 |
Cash flow from operations | -54,656,000 | -42,168,000 | 9,449,000 | 39,068,000 | -21,939,000 | 162,544,000 | 58,678,000 | -9,605,000 | 29,516,000 | 204,949,000 | 63,751,000 | 28,504,000 | 1,090,000 | -183,096,000 |
Investing Activities | ||||||||||||||
capital expenditure | ||||||||||||||
Change in Investments | 68,457,000 | 12,189,000 | -16,586,000 | 0 | 20,570,000 | 47,637,000 | -78,397,000 | -18,986,000 | 17,182,000 | 137,814,000 | -661,000 | 661,000 | 0 | 0 |
cash flow from investments | ||||||||||||||
Financing Activities | ||||||||||||||
Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Group/Directors Accounts | 120,245,000 | 0 | 0 | 0 | 0 | -130,230,000 | -5,584,000 | 11,645,000 | 86,759,000 | -62,310,000 | -8,065,000 | 10,997,000 | 55,643,000 | 41,145,000 |
Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Long term loans | -35,278,000 | -2,688,000 | -3,842,000 | 41,808,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Hire Purchase and Lease Commitments | -1,380,000 | -1,243,000 | -1,556,000 | 23,291,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
share issue | ||||||||||||||
interest | -4,898,000 | -3,615,000 | -4,429,000 | -4,731,000 | -3,991,000 | -3,748,000 | -2,332,000 | -2,306,000 | -552,000 | -958,000 | -363,000 | 2,966,000 | -20,024,000 | 746,000 |
cash flow from financing | 29,268,000 | 80,734,000 | 701,000 | 69,111,000 | 2,725,000 | -108,645,000 | -63,637,000 | 14,354,000 | 79,270,000 | -56,171,000 | -35,641,000 | -1,029,000 | 38,315,000 | 231,847,000 |
cash and cash equivalents | ||||||||||||||
cash | 668,000 | 174,000 | -29,000 | 35,000 | -230,000 | 274,000 | -8,466,000 | 8,485,000 | -370,000 | 297,000 | -285,000 | -1,576,000 | 93,000 | 1,940,000 |
overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
change in cash | 668,000 | 174,000 | -29,000 | 35,000 | -230,000 | 274,000 | -8,466,000 | 8,485,000 | -370,000 | 297,000 | -285,000 | -1,576,000 | 93,000 | 1,940,000 |
P&L
December 2022turnover
699.7m
-7%
operating profit
28.5m
-12%
gross margin
23.6%
+5.16%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
December 2022net assets
185.7m
-0.14%
total assets
455.8m
-0.19%
cash
1m
+1.95%
net assets
Total assets minus all liabilities
bayer public limited company company details
company number
00935048
Type
Public limited with Share Capital
industry
46460 - Wholesale of pharmaceutical goods
incorporation date
July 1968
age
56
accounts
Full Accounts
ultimate parent company
previous names
N/A
incorporated
UK
address
400 south oak way, reading, berkshire, RG2 6AD
last accounts submitted
December 2022
bayer public limited company Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to bayer public limited company.
bayer public limited company Companies House Filings - See Documents
date | description | view/download |
---|